The Olympus Corporation has provided $50m in funding to a new subsidiary it founded called Olympus Innovation Ventures. The company hopes that the venture capital fund can identify and acquire start-ups that “improve patient outcomes, radically advance the detection and treatment of disease, and transform the surgery suite.”
The venture capital fund will focus on gastroenterology, respiratory, and urology technologies that will contribute to Olympus’ broader portfolio.